Octagam 10%

intravenous immunoglobulin (IVIG) · Octapharma

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Octagam 10%, covering 2014-05-05 to 2024-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression [Phase 3]